The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection

BACKGROUND AND OBJECTIVES: Convalescent plasma has attracted significant attention as a therapeutic option against infectious agents for more than a century. In March 2020, the use of Convalescent COVID-19 plasma (CCP) as a new research drug for COVID-19 treatment was approved by the FDA. The develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazeli, Alieh, Sharifi, Shahin, Mohammadi, Saeed, Bahraini, Mehran, Arabkhazaeli, Ali, Jelveh, Nooshin, Eshghi, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554042/
https://www.ncbi.nlm.nih.gov/pubmed/34774440
http://dx.doi.org/10.1016/j.transci.2021.103302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554042/
https://www.ncbi.nlm.nih.gov/pubmed/34774440
http://dx.doi.org/10.1016/j.transci.2021.103302

Ejemplares similares